VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $12.6B | +14.1% |
| Gross profit | $10.8B | +13.6% |
| Operating income | $4.8B | +7.9% |
| Net income | $4.4B | +7.8% |
| EPS | $17.18 | +8.3% |
| Free cash flow | $3.8B | +1.3% |